TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
44 hedge funds and large institutions have $23.6M invested in Talis Biomedical Corporation Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.54M | |
| 2 | +$157K | |
| 3 | +$145K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$49.6K |
| 5 |
Renaissance Technologies
New York
|
+$38.3K |
Top Sellers
| 1 | -$2.72M | |
| 2 | -$260K | |
| 3 | -$258K | |
| 4 |
PP
PDT Partners
New York
|
-$140K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$139K |